Yüklüyor......
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer
Advances in the immunotherapy of cancer have prolonged survival for cancer patients, but the clinical and financial impact of treatments must be considered in determining the overall clinical utility and economic value of therapeutic agents. Quality-adjusted life years and incremental cost-effective...
Kaydedildi:
| Yayımlandı: | J Immunother Cancer |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6724271/ https://ncbi.nlm.nih.gov/pubmed/31481112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0707-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|